RenovoRx, Inc. ( RNXT) - Stock Earnings
RNXT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
RNXT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.9 million USD | 238000 USD |
| 2026Q1 | -3.5 million USD | 563000 USD |
| 2026Q2 | -2.9 million USD | 909000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
RNXT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.2 million USD | — USD |
| 2024 | -8.8 million USD | 43000 USD |
| 2025 | -11.2 million USD | 1.1 million USD |
| 2026 Est. | — | — |
RNXT
Price: $1.20
52 week price:
Earnings Per Share: -0.27 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 20500
Market Capitalization: 66.2 million